跳转至内容
Merck
CN

L050030

Cap B

configured for ABI

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

NACRES:
NA.21
UNSPSC Code:
12352200
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


type

for DNA synthesis

Quality Level

product line

Proligo Reagents

form

liquid

storage condition

dry at room temperature

impurities

≤200 ppm water content (Karl Fischer)

color

clear

suitability

conforms to structure (GC, Formulation)

compatibility

configured for ABI

General description

Cap B solution contains tetrahydrofuran (THF), pyridine, and N-methylimidazole (NMI). It is mixed in situ with Cap A solution during the capping (acetylation) reaction. Pyridine is applied as a mild base while NMI provides a powerful acylation catalyst.

Preparation Note

四氢呋喃/N-甲基咪唑·84/16 (v/v)

Other Notes

Cap B solution, containing tetrahydrofuran (THF) and N-methylimidazole (NMI), is mixed in situ with Cap A solution during the capping (acetylation) reaction. Lutidine is applied as a mild base while NMI provides a powerful acylation catalyst.


Still not finding the right product?

Explore all of our products under Cap B


signalword

Danger

Hazard Classifications

Acute Tox. 4 Oral - Carc. 2 - Eye Dam. 1 - Flam. Liq. 2 - Repr. 2 - Skin Corr. 1B - STOT SE 3

target_organs

Central nervous system, Respiratory system

supp_hazards

存储类别

3 - Flammable liquids

wgk

WGK 2

flash_point_f

6.1 °F

flash_point_c

-14.4 °C

法规信息

危险化学品

此项目有



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



全球贸易项目编号

货号GTIN
L050030-2.5L04061838216045
L050030-6X180ML04061838216052
L050030-6X450ML04061838216069